Show results for
Refine by
Targeted Boron Drugs Equipment & Supplies In In Canada
107 equipment items found
Manufactured by:OPKO Health, Inc. based inMiami, FLORIDA (USA)
In our Natural Antisense Transcripts Antagonist (AntagoNAT) technology, an oligonucleotide molecule is designed to interfere with regulatory gene expression in order to enhance production of endogenous functional proteins. This strategy is unique and contrasts with established approaches which down-regulate protein production. This platform can lead to the discovery of new drugs to target ...
Manufactured by:EirGenix, Inc based inNew Taipei City, TAIWAN
Product: TSY0110 (EG12043) Antibody-Drug Conjugate. Indication: Cancer. Target: HER2. Status: ...
Manufactured by:Advanced Accelerator Applications SA based inRueil-Malmaison Cedex, FRANCE
AAA brand names for [18F]-choline (FCH). ...
Manufactured by:Advanced Accelerator Applications SA based inRueil-Malmaison Cedex, FRANCE
AAA brand names for 6-fluoro-[18F]-L-DOPA, a DOPA analog. Neurology, ...
by:Onegene Biotechnology based inSuwon, SOUTH KOREA
Onegene Biotechnology is pioneering multi-target therapeutics to create breakthrough medicines that will transform the lives of people with complex and chronic diseases. Onegene’s proprietary platform, UniStac®, allows rapid expansion of promising combinations of the targets into a single multi-target molecule with enzyme-mediated protein-protein conjugation technology while removing ...
by:Zymeworks Inc based inVancouver, BRITISH COLUMBIA (CANADA)
ZW49 is a HER2-targeted antibody drug conjugate (ADC) developed using Zymeworks’ proprietary Azymetric™ and ZymeLink™ platforms. ZW49 is currently being evaluated in a Phase 1 clinical trial as a treatment for patients with locally advanced or metastatic HER2-expressing cancers that have progressed following treatment with existing approved therapies, including HER2-targeted ...
Manufactured by:Biosensors International Group, Ltd. based inSingapore, SINGAPORE
BA9, an effective Cytostatic Limus Drug: Rapid 28 day BA9 transfer to the vessel wall achieved through enhanced high lipophilicity delivering: Greater Local Bioavailability. Targeted Drug Release. Local tissue warehousing allowing Sustained Tissue Release, with Therapeutic Effect up to 100 days12,13. Longer Half Life than other commonly used Limus Drugs, approximately 20 days in tissue12,13. ...
Manufactured by:Confo Therapeutics based inGhent/Zwijnaarde, BELGIUM
With its unique antibody-based technology, Confo Therapeutics aims to overcome the current limitations of GPCR drug discovery in order to fully realize the potential of GPCRs as drug ...
Manufactured by:Concept Medical Inc. based inTampa, FLORIDA (USA)
Conversion of Sirolimus drug into sub-micron sized particles; Nanocarriers created by encapsulation of sub-micron sized Sirolimus drug into highly biocompatible drug Carrier-phospholipid; Upon inflation of MagicTouch SCB at target site, nanocarriers with Sirolimus drug inside gets transferred to the vessel wall following the principle of co-efficient diffusion; Upon body pH variation, ...
Manufactured by:Skyepharma Production SAS based inSaint-Quentin-Fallavier, FRANCE
Geoclock® is a validated tab in tab (press coated tablet) oral drug delivery technology that allows for timed release of active ingredient from the tablet (oral chronotherapy), independent of food or pH. Geoclock® can additionally be used for multiple pulse delivery of one or more drugs with pre-determined time intervals between the pulses, or to target colonic release of drugs. Where ...
Manufactured by:LVD Biotech based inSant Vicenç dels Horts, SPAIN
Our Drug-Eluting Technology (Transfertech) has been designed to guarantee the durability of the coating in the first navigation stage until reaching the injury. The balloon surface is covered with multiple and independent nano drops layers, providing a flexible coating that adapts to the balloon movement and ensures the release of the drug in the target lesion, without particle loss in the blood ...
Manufactured by:Vitrosens Biotechnology A.S. based inÜmraniye, TURKEY
It is created for the qualitative detection of total of 14 drugs and drug metabolites (AMP, BAR, BZO, BUP, COC, THC, MET, MTD, MDMA, MOP, OXY, PCP, PPX, and TCA) simultaneously by using human oral fluid samples. ...
by:XACT Robotics Ltd. based inCaesarea, ISRAEL
Combines image-guided planning and real-time monitoring with precise robotic insertion and S-Drive™ technology to deliver instruments to the desired target in the body with enhanced accuracy, consistency, and efficiency. ...
Distributed by:MoBiTec GmbH based inGoettingen, GERMANY
COVID-19 Research: Antiviral Drug Target ? The COVID-19 pandemic is caused by infection of SARS-CoV-2 or severe acute respiratory syndrome coronavirus 2, a positive-sense single-stranded RNA virus. The RNA dependent RNA polymerase (RdRp) is a key drug target for this deadly virus. The gel-based SARS-CoV-2 RdRp assay can be used for visualization of the RNA molecules synthesized by the RNA ...
Manufactured by:Evox Therapeutics Limited based inOxford, UNITED KINGDOM
Targeted delivery of nanoparticles is an area that has been intensively researched. Targeted drug delivery has a role to play in the delivery of many if not all drugs, but targeted delivery systems are critical for the delivery of nucleic acid-based agents such as siRNA and CRISPR-Cas ...
Manufactured by:Cellworks Research India Private Limited based inBangalore, INDIA
The Cellworks Platform biosimulates how a patient’s unique cancer will respond to therapies prior to treatment and identifies novel drug combinations for treatment-refractory patients. Therapy biosimulation is the ability to predict the phenotype response of a human cell to an external stimulus, such as a drug ligand or radiation. We utilize this technology, to determine a patient’s ...
Manufactured by:Eutilex Co.,Ltd. based inSeoul, SOUTH KOREA
Fully humanized therapeutic monoclonal antibody. This could convert type II macrophage to Type I. Anti-tumor efficacy of the antibody can be achieved by modulating tumor ...
Manufactured by:Eutilex Co.,Ltd. based inSeoul, SOUTH KOREA
MVR CAR-T can be used against HLA-DR positive cancer, as well as B cell malignancy. The epitopes recognized by HLA-DR are not shed or internalized, enabling stable binding to human lymphoma cells. MVR CAR-T can also be used in patients who relapse after CD19 CAR-T treatment. Reduction of cytokine secretion due to selective killing of tumor ...
Manufactured by:Adrenomed AG based inBerlin, GERMANY
The Company’s lead product candidate is Adrecizumab (HAM8101; INN: enibarcimab), a clinical-stage, first-in-class drug targeting loss of vascular integrity. The strong rationale for Adrecizumab is supported by the elegance of its mode of action, a monoclonal antibody that on binding to its target Adrenomedullin preserves its functionality as regulator of vascular ...
by:Orion Biotechnology Canada, Ltd. based inOttawa, SWITZERLAND
G Protein-Coupled Receptors (GPCRs) are involved in a wide range of physiological and pathological processes and represent a large class of drug targets accounting for >30% of all drugs on the market. These drugs, however, only cover 15% of the entire GPCR family, and many valuable receptors remain undrugged. In particular, GPCRs whose natural ligands are large peptides or small proteins are ...